Battling Lung Cancer With Combination Drug Therapy
Combination drug therapy may be needed to combat non-small cell lung cancer (NSCLC), according to a study by the Translational Genomics Research Institute (TGen) and Van Andel Research Institute (VARI). The study, STAT3 is Activated by JAK2 Independent of Key Oncogenic Driver Mutation in Non-Small Cell Lung Carcinoma, was published online by the Public Library of Science (PLoS) ONE. The study found that in NSCLC - the most common form of lung cancer - that the STAT3 gene is activated in some NSCLC cell lines by the JAK2 protein... (Source: Health News from Medical News Today)
Plan to Take British Health Records Into Virtual Reality Encounters Bureaucratic Reality, Shuts Down
Source: Peter Suderman, Reason Content: #8220;It#8217;s hard to imagine a better environment in which to test a government-run health information technology system than Britain#8217;s National Health Service. The system is fully socialized, with a single government payer, universal enrollment, and doctors employed directly by the state. There are roughly 60 million beneficiaries, which is big [...] (Source: ICMCC: The International Council on Medical and Care Compunetics)
